Rifampicin resistant tuberculosis
Clinical trials for Rifampicin resistant tuberculosis explained in plain language.
Never miss a new study
Get alerted when new Rifampicin resistant tuberculosis trials appear
Sign up with your email to follow new studies for Rifampicin resistant tuberculosis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 6-Month TB drug cocktail could replace Year-Long ordeal
Disease control Recruiting nowThis study tests a new 6-month treatment called BPaLM for people with multidrug-resistant tuberculosis (MDR-TB). The goal is to see if it works as well as the current 18+ month regimen. About 55 adults in France will receive the shorter treatment, and their outcomes will be compa…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New hope for Drug-Resistant TB: experimental combo trial launches
Disease control Recruiting nowThis study tests a new drug called JDB0131, combined with other TB medications, in 60 people with rifampin-resistant tuberculosis. Participants will receive one of two doses of JDB0131 or a standard drug (delamanid) for 8 weeks. The goal is to see which combination clears the bac…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Phase 2 • Sponsor: WestVac Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could nurses replace doctors for TB treatment? major trial underway
Disease control Recruiting nowThis study compares nurse-led treatment for drug-resistant tuberculosis (TB) in local clinics to standard doctor-led care in hospitals. About 2,944 people will take part across South Africa. The goal is to see if nurse-led care works just as well, is safe, and lowers costs for pa…
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Massive global study aims to slash TB deaths with smarter testing
Diagnosis Recruiting nowThis study aims to find faster, simpler, and cheaper ways to diagnose tuberculosis (TB), a disease that kills over a million people each year. Researchers will test new diagnostic tools on over 26,000 adults in 10 countries who have a cough lasting two weeks or more, or who have …
Matched conditions: RIFAMPICIN RESISTANT TUBERCULOSIS
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC